NAOV

NanoVibronix (NAOV)

NanoVibronix Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NAOV

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	02:25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NAOV	NanoVibronix Inc
2024/05/14	21:30	Business Wire	NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield	NASDAQ:NAOV	NanoVibronix Inc
2024/05/01	21:00	Business Wire	NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award	NASDAQ:NAOV	NanoVibronix Inc
2024/04/09	21:30	Business Wire	NanoVibronix Issues Letter to Stockholders	NASDAQ:NAOV	NanoVibronix Inc
2024/03/28	21:30	Business Wire	NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield	NASDAQ:NAOV	NanoVibronix Inc
2024/02/27	07:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2024/02/24	09:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2024/02/24	09:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2024/02/24	09:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2024/02/24	09:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2024/02/15	05:45	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:NAOV	NanoVibronix Inc
2024/01/18	06:31	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:NAOV	NanoVibronix Inc
2024/01/18	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAOV	NanoVibronix Inc
2023/12/12	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAOV	NanoVibronix Inc
2023/12/07	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2023/12/06	23:00	Business Wire	NanoVibronix Featured in Your Bladder Health Magazine	NASDAQ:NAOV	NanoVibronix Inc
2023/12/05	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2023/12/05	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2023/12/05	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2023/12/05	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2023/12/05	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:NAOV	NanoVibronix Inc
2023/12/05	06:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAOV	NanoVibronix Inc
2023/12/04	23:00	Business Wire	NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	NASDAQ:NAOV	NanoVibronix Inc
2023/11/28	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAOV	NanoVibronix Inc
2023/11/28	23:00	Business Wire	NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan	NASDAQ:NAOV	NanoVibronix Inc
2023/11/21	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAOV	NanoVibronix Inc
2023/11/21	22:30	Business Wire	NanoVibronix Regains Nasdaq Compliance	NASDAQ:NAOV	NanoVibronix Inc
2023/11/14	22:30	Business Wire	NanoVibronix Issues Letter to Shareholders	NASDAQ:NAOV	NanoVibronix Inc
2023/11/14	06:44	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:NAOV	NanoVibronix Inc
2023/11/07	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:NAOV	NanoVibronix Inc